Log in to your account:
Johnson & Johnson (JNJ) temporarily paused its COVID-19 vaccine candidate clinical trials due to an unexplained illness
October 12, 2020 10:20 PM
Johnson & Johnson (NYSE: JNJ) temporarily paused its COVID-19 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
J&J (JNJ) CFO: Notified of Sick Person at One Trial Site 36 Hours Ago, Still Expects Data from Trial Before Year- End - Bloomberg, Citing Conf. Call
October 13, 2020 7:55 AM